Modification of dopamine release by selective inhibitors of MAO-B

Neurobiology

Volumn 8, Issue 2, 2000, Pages 137-142

  Finberg, J P M ^a   Lamensdorf, I ^a   Armoni, T ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

phenylethylamine; Clorgyline; Deprenyl; Dopamine; Neuronal reuptake

Indexed keywords

AMPHETAMINE; CLORGYLINE; DOPAMINE; MONOAMINE OXIDASE B INHIBITOR; PHENETHYLAMINE; RASAGILINE; SELEGILINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG EFFECT; GUINEA PIG; MALE; NERVE CELL MEMBRANE; NONHUMAN; PARKINSON DISEASE; SYNAPSE;

ANIMALS; CLORGYLINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; GUINEA PIGS; MALE; MICRODIALYSIS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PIPERAZINES; SELEGILINE;

EID: 0033774251     PISSN: 12168068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Guineapig striatum as a model of human DA deamination: The role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic DA metabolism
2. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons
3. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat
4. Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey
5. On the substrate specificities of the two forms of monoamine oxidase
6. Dopamine metabolism in the guinea pig striatum: Role of monoamine oxidase A and B
7. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors
8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo
9. Deprenyl in the treatment of Parkinson's disease: Clinical effects and speculation on mechanism of action
10. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding
11. 2-Phenylethylamine: A modulator of catecholamine transmission in the mammalian central nervous system?
12. Inhibition of monoamine oxidase B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum
13. Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca fascicularis) brain
14. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter
15. Further proof that (-)-deprenyl fails to facilitate mesolimbic dopaminergic activity
16. Distinct monoamine oxidase populations in primate brain